September 26, 2022

Now Enrolling: The EA2205 research study is testing a new treatment approach for a rare form of liver cancer

Researchers at ECOG-ACRIN are studying if they can improve results for patients with liver cancer by giving chemotherapy along with drugs that help the body’s immune system fight cancer
September 26, 2022

Ongoing Trials: A closer look at ECOG-ACRIN’s studies for patients with head and neck cancer

These five clinical trials are exploring possible new treatments for adults with head and neck cancers. These cancers can involve the mouth, throat, voice box (larynx)—or, much more rarely, the nose/sinuses or saliva glands
June 28, 2022

Ongoing Trial: As the TMIST breast cancer screening trial passes the halfway mark, leaders continue efforts to recruit women from diverse backgrounds

Reaching more women in local communities, especially women of color, will ensure that the trial results apply to all women—and move health equity forward
March 24, 2022

Now Enrolling: The EAQ202 clinical trial seeks to provide young people with cancer a better way to report their experiences during cancer treatment

This pilot study will test some exciting new interactive features that ECOG-ACRIN would like to add to the surveys and questionnaires used to evaluate the experiences of young patients
March 24, 2022

Ongoing Trial: The BAMM2 trial (EA6191) explores adding the drug hydroxychloroquine to standard treatment for certain patients with melanoma that has progressed after immunotherapy

This study is evaluating the effect of adding hydroxychloroquine to the usual treatment for patients with advanced, BRAF-mutant melanoma